Digital Health In Neurology Market Size, Share and Growth Outlook, 2026

Digital Health In Neurology Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Digital Health In Neurology Market size is forecast to increase from $48.45 Billion in 2026 to $276.1 Billion in 2034 at a CAGR of 24.3% between 2026 and 2034.

The Digital Health In Neurology market report provides detailed analysis and outlook of Digital Health In Neurology segments including By Component (Hardware, Software, Services), By Technology (Telemedicine, Digital Therapeutics, mHealth Applications, Wearable Devices, AI-driven Diagnostics), By Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Stroke & Neuro-rehabilitation, Sleep Disorders), By End-User (Patients, Healthcare Providers, Payers, Pharmaceutical Companies) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Digital Health in Neurology Industry Overview

Artificial Intelligence and Connected Technologies Are Reshaping Neurological Care

The digital health in neurology industry is advancing rapidly through the integration of artificial intelligence, wearable devices, smartphone-based diagnostics, brain-computer interfaces, and cloud-connected neurological monitoring platforms. Healthcare providers are increasingly adopting digital solutions to improve disease detection, symptom monitoring, treatment personalization, and long-term neurological care. These technologies are enabling clinicians to collect real-world neurological data continuously, supporting more precise management of conditions such as Parkinson’s disease, essential tremor, dementia, and severe neurological impairments.

AI-Powered Wearables Expand Therapeutic Options for Movement Disorders

One of the most significant developments in the digital health in neurology industry is the emergence of intelligent wearable therapeutic devices. Fasikl received U.S. FDA 510(k) clearance for its Felix NeuroAI Wristband, a non-invasive bioelectronic therapy platform designed to address upper limb tremor-related functional limitations in adults with essential tremor. The wearable device connects directly to a cloud-based platform and utilizes edge computing algorithms to continuously analyze patient movement patterns. Through real-time brain-AI co-adaptation and dynamic stimulation, the system provides ongoing symptom management throughout daily activities. This advancement highlights the growing role of artificial intelligence in delivering personalized neurological therapies outside traditional clinical settings.

Smartphone-Based Digital Biomarkers Improve Neurological Monitoring

Mobile health technologies are becoming increasingly important for neurological disease management and assessment. Kneu Health launched its precision neurology platform in the United States following FDA clearance of its smartphone-based tremor measurement module. The application guides patients with Parkinson’s disease and dementia through structured motor assessments while utilizing built-in smartphone sensors to capture subtle movement changes. These measurements generate clinically relevant digital biomarkers without requiring specialized hardware. By enabling remote monitoring and continuous neurological assessment, smartphone-based diagnostic platforms are helping clinicians gain deeper insights into disease progression and treatment effectiveness.

Brain-Computer Interface Technologies Advance Neural Data Collection

The digital health in neurology industry is also benefiting from advances in neurotechnology and brain-computer interface development. Precision Neuroscience obtained FDA 510(k) clearance for its Layer 7 Cortical Interface, an ultra-thin high-density microelectrode array containing 1,024 electrodes. The device is designed to rest directly on the surface of the cerebral cortex and may remain implanted for up to 30 days. This technology enables the collection of high-resolution neural activity data that can be used to train advanced brain-computer interface algorithms. Such innovations are supporting the development of future neuroprosthetic systems aimed at restoring communication, mobility, and functional independence for individuals living with severe neurological conditions.

Digital Health In Neurology Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Digital Health In Neurology market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Medtronic plc , Royal Philips , Aptar Digital Health , MindMaze, Neuralink Corp., NeuroPace, Inc., Synaptive Medical, Cionic , Insightec Ltd., Beacon Biosignals. The Digital Health In Neurology market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Digital Health In Neurology industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Digital Health In Neurology Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Digital Health In Neurology companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Digital Health In Neurology markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Digital Health In Neurology Market Competitive Benchmarking and Company Analysis

Leading companies in Digital Health In Neurology industry include- Medtronic plc , Royal Philips , Aptar Digital Health , MindMaze, Neuralink Corp., NeuroPace, Inc., Synaptive Medical, Cionic , Insightec Ltd., Beacon Biosignals. The Digital Health In Neurology market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Digital Health In Neurology Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Digital Health In Neurology market remains one of the strongest-performing segments in the country.
The US Digital Health In Neurology Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Digital Health In Neurology market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Digital Health In Neurology industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Digital Health In Neurology markets

Canada's strong Digital Health In Neurology sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Digital Health In Neurology market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Digital Health In Neurology Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Digital Health In Neurology market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Digital Health In Neurology population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Digital Health In Neurology industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Digital Health In Neurology market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Digital Health In Neurology sales through 2034

France Digital Health In Neurology companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Digital Health In Neurology Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Digital Health In Neurology distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Digital Health In Neurology Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Digital Health In Neurology market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Digital Health In Neurology industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Digital Health In Neurology industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Digital Health In Neurology Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Digital Health In Neurology market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Digital Health In Neurology market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Digital Health In Neurology Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Digital Health In Neurology Market Segmentation

By Component
Hardware
Software
Services
By Technology
Telemedicine
Digital Therapeutics
mHealth Applications
Wearable Devices
AI-driven Diagnostics
By Application
Alzheimer’s Disease
Parkinson’s Disease
Multiple Sclerosis
Epilepsy
Stroke & Neuro-rehabilitation
Sleep Disorders
By End-User
Patients
Healthcare Providers
Payers
Pharmaceutical Companies

Top Companies in Digital Health In Neurology Industry

Medtronic plc
Royal Philips
Aptar Digital Health
MindMaze
Neuralink Corp.
NeuroPace, Inc.
Synaptive Medical
Cionic
Insightec Ltd.
Beacon Biosignals

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Tariff-Driven Regionalization of Supply Chains

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025